Last year, AstraZeneca reported that a new drug to treat Wilson disease developed by its Alexion rare diseases unit had hit the mark in a phase 3 trial, setting it on course for regulatory filings.

Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.

Hospitalizations and deaths show how severe COVID-19 infections are. Wastewater and emergency room data show changes in COVID-19 spread in a community. Reported case numbers do not show all the ...

DiveWire guarantees visibility for your news announcements through instant distribution to Construction Dive’s audience and its 199,000 newsletter subscribers for 21 days.